Call Buying Activity in Elanco Animal Health (ELAN) Targets Upside in Shares Through March -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
UPDATE: Credit Suisse Upgrades Elanco Animal Health (ELAN) to Outperform
February 26, 2021 4:39 AM EST(Updated - February 26, 2021 5:27 AM EST)
Credit Suisse analyst Erin Wilson Wirght upgraded Elanco Animal Health (NYSE: ELAN) from Neutral to Outperform with a price target of $38.00 (from $33.00).
The analyst comments "e are upgrading Elanco (ELAN) to Outperform (from Neutral) on incremental... More
Elanco Animal Health (ELAN) Tops Q4 EPS by 3c, Offers Guidance
February 24, 2021 6:40 AM ESTElanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.12, $0.03 better than the analyst estimate of $0.09. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.06 billion.
GUIDANCE:
Elanco Animal Health sees Q1 2021 EPS of $0.20-$0.25, versus the... More
